Potential diagnostic, prognostic, and predictive biomarkers of gastric cancer

Ousman Mohammed,Solomon Tebeje Gizaw,Maria Degef

DOI: https://doi.org/10.1002/hsr2.2261

2024-07-21

Abstract:Background: Gastric cancer (GC), a malignant epithelial tumor, is the fourth leading cause of cancer-related death worldwide. Therapeutic strategies for GC, despite the biggest challenges, can significantly improve survival rates through early detection and effective screening methods. Aim: To provide brief information on the necessity of multiple specific diagnostic, prognostic, and predictive markers for GC. Methods: This review was conducted using a variety of search engines, including PubMed Central, Scopus, Web of Science, Google Scholar, and others. Results: Some potential biomarkers that provide essential information include circulating tumor cells (CTCs), DNA methylation, claudin 18.2, fibroblast growth factor receptor 2 (FGFR2), long noncoding RNAs (lncRNAs), cell-free DNA (cfDNA), microRNAs, and serum pepsinogens. Conclusion: Multiple tumor markers are essential for screening, tumor identification, staging, prognostic assessment, and monitoring recurrence after therapy due to the absence of a single tumor indicator for diagnosing, prognosticating, and predicting GC.